PPAR-γ agonists as therapy for diseases involving airway neutrophilia

Birrell M.A., Patel H.J., McCluskie K., Wong S., Leonard T., Yacoub M.H., Belvisi M.G.

Source: Eur Respir J 2004; 24: 18-23
Journal Issue: July
Disease area: Airway diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Birrell M.A., Patel H.J., McCluskie K., Wong S., Leonard T., Yacoub M.H., Belvisi M.G.. PPAR-γ agonists as therapy for diseases involving airway neutrophilia. Eur Respir J 2004; 24: 18-23

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Role of NF-?B and PPAR-? in lung inflammation induced by monocyte-derived microparticles
Source: Eur Respir J 2011; 37: 1494-1502
Year: 2011



Regulation of eotaxin gene transcription by peroxisome proliferator-activated receptor γ agonists in human airway smooth muscle cells: interactions with glucocorticoids and β2-agonists
Source: Annual Congress 2005 - Inflammation and the airway smooth muscle: cellular and pharmacological interactions
Year: 2005


The perxisome proliferator-activated receptor gamma agonist, rosiglitazone, inhibits IL-8 synthesis by airway epithelial cells stimulated with monocyte-derived microparticles
Source: Annual Congress 2007 - Epithelial networks in the airways
Year: 2007


Preserved compliance and reduced inflammation after activation of peroxisome proliferator-activated receptor (PPAR)a in a murine model of acute lung injury
Source: Annual Congress 2006 - Novel pathogenic aspects of acute lung injury and acute respiratory distress syndrome (ARDS)
Year: 2006


Peroxisome proliferator-activated receptors: a therapeutic target in COPD?
Source: Eur Respir J 2008; 31: 502-508
Year: 2008



Activation of airway epithelial cell inhibited by peroxisome proliferator-activated receptor γ
Source: Eur Respir J 2006; 28: Suppl. 50, 229s
Year: 2006

The effect of peroxisome proliferator-activated receptor-? ligands on in vitro and in vivo models of COPD
Source: Eur Respir J 2014; 43: 409-420
Year: 2013



Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPD
Source: Eur Respir J 2007; 30: 245-252
Year: 2007



Peroxisome proliferator activated receptor gamma (PPARγ) agonist rosiglitizone inhibits upregulation of mucin gene expression in two airway epithelial cell lines
Source: Eur Respir J 2005; 26: Suppl. 49, 97s
Year: 2005

Peroxisome proliferator-activated receptor-α reduces inflammation and vascular leakage in a murine model of acute lung injury
Source: Eur Respir J 2008; 32: 1344-1353
Year: 2008



Relationship between peroxisome proliferator-activated receptor α and neutrophils in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 452s
Year: 2004

Peroxisome proliferator-activated receptor gamma antagonist, GW9662, inhibits microparticles generation by calcium ionophore-stimulated monocytes/macrophages
Source: Annual Congress 2008 - Novel experimental approaches to understanding asthma and COPD
Year: 2008


The relationship of peroxisome proliferator activated receptor γ ligands and IL-6 in sepsis of rats
Source: Annual Congress 2009 - Acute lung injury and biomarkers
Year: 2009

The interaction of glucocorticoid and peroxisome proliferator-activated receptor γ agonist in asthmatic mice
Source: Eur Respir J 2006; 28: Suppl. 50, 226s
Year: 2006

Impacts of peroxisome proliferator-activated receptor gamma activation on cigarette smoke-induced exacerbated response to bacteria
Source: Eur Respir J 2015; 45: 191-200
Year: 2015



Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease
Source: Eur Respir Rev 2006; 15: 211-212
Year: 2006



Diminished peroxisome proliferator-activated receptor (PPAR) regulation as a potential mechanism for the persistent inflammation in chronic obstructive pulmonary disease
Source: Eur Respir J 2006; 28: Suppl. 50, 856s
Year: 2006

Peroxisome proliferator-activated receptor γ inhibits acrolein-induced airway mucus hypersecretion in rats
Source: Annual Congress 2008 - Inflammatory trigger mechanisms in asthma and COPD
Year: 2008


PPAR ligands decrease human airway smooth muscle cell migration and extracellular matrix synthesis
Source: Eur Respir J 2013; 41: 425-432
Year: 2013



The role of peroxisome proliferator-activated receptor γ in pulmonary hypertension
Source: Annual Congress 2009 - Pulmonary circulation II
Year: 2009